Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avricore Health Inc V.AVCR

Alternate Symbol(s):  AVCRF

Avricore Health Inc. is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at advancing pharmacy practice and patient care. The Company is involved in the business of health data and point-of-care technologies (POCT). HealthTab, its flagship offering, is a turnkey point-of-care testing solution that combines point-of-care technologies with a secure, cloud-based platform for tackling pressing global health issues. With just a few drops of blood from a finger prick, the system generates lab-accurate results on the spot and data is reported in real time. The test menu includes up to 23 key biomarkers for screening and managing chronic diseases, such as diabetes and heart disease (e.g., HbA1c, Lipid Profile, eGFR). The HealthTab also has capabilities for bacterial and viral tests, such as strep and COVID-19. The HealthTab platform transforms pharmacies into community point-of-care diagnostic centers.


TSXV:AVCR - Post by User

Bullboard Posts
Post by kingposton Oct 17, 2015 6:07pm
223 Views
Post# 24201864

Could Generics be the hot ticket in the healthcare sector.?

Could Generics be the hot ticket in the healthcare sector.?Although the bio-techs and healthcare ar large has had a correction recently , the impetus seems to be the run away pricing of new and old patented brand drugs... Companies like Valaent and Concordia are right at the centre of this .... they have a history of buying drug rights and raising prices but society can only pay so much so this can and has back fired on those companies...Unfortunately the sell off was indiscriminate and wide spread across the healthcare indiustry... In the future However, smart investment , government and other stakeholders  will realize this is throwing the baby out with the bath water in the sense that generics drug companies are a direct help, to the problem beimg addressed....lowering drug costs to society...This is why I think what seems to be an undertoe in the healthcare sector will likely end up being very supportive to generics and NPH's business (when sound minds prevail)..
Bullboard Posts